Search Results - "LAURIE, J. A"

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer by O'Connell, M J, Laurie, J A, Kahn, M, Fitzgibbons, Jr, R J, Erlichman, C, Shepherd, L, Moertel, C G, Kocha, W I, Pazdur, R, Wieand, H S, Rubin, J, Vukov, A M, Donohue, J H, Krook, J E, Figueredo, A

“…This study had two major goals: (1) to assess the effectiveness of a regimen of fluorouracil (5-FU) plus levamisole plus leucovorin as postoperative surgical…”
Get more information

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A, Tangen, C M, Ungerleider, J S, Emerson, W A, Tormey, D C, Glick, J H

“…To determine the effectiveness of fluorouracil plus levamisole administered postoperatively to patients with resected stage II (Dukes' B2) colon cancer. This…”
Get more information

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma by Poon, M A, O'Connell, M J, Moertel, C G, Wieand, H S, Cullinan, S A, Everson, L K, Krook, J E, Mailliard, J A, Laurie, J A, Tschetter, L K

“…The purpose of this study was to evaluate the effectiveness of several new approaches designed to enhance the activity of fluorouracil (5-FU) in the management…”
Get more information

An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer by Moertel, Charles G, Fleming, Thomas R, Macdonald, John S, Haller, Daniel G, Laurie, John A, Tangen, Cathy

“…Objective.—To determine the effectiveness of carcinoembryonic antigen (CEA) monitoring in detecting surgically curable recurrence of colon…”
Get full text

Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity by Williams, M S, Burk, M, Loprinzi, C L, Hill, M, Schomberg, P J, Nearhood, K, O'Fallon, J R, Laurie, J A, Shanahan, T G, Moore, R L, Urias, R E, Kuske, R R, Engel, R E, Eggleston, W D

“…Considerable pilot data and clinical experience suggested that an aloe vera gel might help to prevent radiation therapy-induced dermatitis. Two Phase III…”
Get more information

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A

“…To determine the frequency and nature of hepatic toxicity associated with fluorouracil (5-FU) plus levamisole adjuvant therapy. All patients had resection of…”
Get more information

Surgery for recurrent colon cancer : Strategies for identifying resectable recurrence and success rates after resection by GOLDBERG, R. M, FLEMING, T. R, TANGEN, C. M, MOERTEL, C. G, MACDONALD, J. S, HALLER, D. G, LAURIE, J. A

Get full text

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A, Tangen, C M, Ungerleider, J S, Emerson, W A, Tormey, D C, Glick, J H, Veeder, M H, Mailliard, J A

“…To determine the effectiveness of two adjuvant therapy regimens in improving surgical cure rates in stage III (Dukes stage C) colon cancer. Randomized,…”
Get full text

An evaluation of postoperative follow-up tests in colon cancer patients treated for cure by Peethambaram, P, Weiss, M, Loprinzi, C L, Novotny, P, O'Fallon, J R, Erlichman, C, O'Connell, M J, Laurie, J A

“…Currently patients with colon cancer who are potentially cured by surgery are followed periodically with physical examinations, blood tests and imaging studies…”
Get more information

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma by Buroker, T R, Moertel, C G, Fleming, T R, Everson, L K, Cullinan, S A, Krook, J E, Mailliard, J A, Marschke, R F, Klaassen, D J, Laurie, J A

“…Three hundred thirty-five previously untreated patients with advanced colorectal carcinoma were randomly assigned to treatment with 5-fluorouracil (5-FU)…”
Get more information

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens by Edmonson, J H, McCormack, G M, Wieand, H S, Kugler, J W, Krook, J E, Stanhope, C R, Everson, L K, Laurie, J A, Ebbert, L P, Malkasian, G D

“…Between March 1985 and January 1987, 103 women with histologically proven stage III-IV ovarian carcinoma were randomly allocated to groups receiving monthly…”
Get more information

Contrast Material Iodides: Potential Effects on Radioactive Iodine Thyroid Uptake by Laurie, Andrew J, Lyon, Sandra G, Lasser, Elliott C

“…The levels of contaminant, free inorganic iodide and iodine were determined in several commonly used ionic and nonionic intravenous contrast media to gain a…”
Get full text

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma by Moertel, Charles G, Fleming, Thomas R, Macdonald, John S, Haller, Daniel G, Laurie, John A, Goodman, Phyllis J, Ungerleider, James S, Emerson, William A, Tormey, Douglas C, Glick, John H, Veeder, Michael H, Mailliard, James A

“…Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive (Stage B 2 ) or had regional nodal involvement (Stage C) were…”
Get full text

Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil by Laurie, J A, Hahn, R G, Therneau, T M, Patel, S R, Mailliard, J A, Windschitl, H E, Twito, D I, Morton, R F, Krook, J E

“…One hundred forty-two patients with progressive, hormonally refractory advanced prostate carcinoma who had not received prior chemotherapy were randomized to…”
Get more information

The effects of contrast media on coagulation factor XII by Laurie, A J, Lyon, S G, Lasser, E C

Get more information

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial by Morton, R F, Jett, J R, McGinnis, W L, Earle, J D, Therneau, T M, Krook, J E, Elliott, T E, Mailliard, J A, Nelimark, R A, Maksymiuk, A W

“…To compare the survival of patients with medically inoperable or unresectable stage III non-small cell lung cancer treated with thoracic radiotherapy alone or…”
Get more information

A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer by Krook, J E, Jett, J R, Fleming, T R, Dalton, R J, Marschke, R F, Cullinan, S A, Windschitl, H E, Everson, L K, Brunk, F S, Laurie, J A

“…One hundred eighty-six patients with advanced non-small-cell lung cancer were randomly assigned to treatment with combined 5-fluorouracil, doxorubicin, and…”
Get more information

Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer by Everson, L K, Jett, J R, O'Fallon, J R, Krook, J E, Dalton, R J, Mailliard, J A, Tschetter, L K, Cullinan, S A, Gerstner, J B, Morton, R F

“…In this study, we evaluated the role of alternating chemotherapy with or without etoposide (VP-16) in patients with extensive-stage small-cell carcinoma (SCC)…”
Get more information

Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma by Brindle, J S, Shaw, E G, Su, J Q, Mailliard, J A, Frank, A R, Laurie, J A, McLean, M, Tackett, D M, Owens, D T

“…The primary goal of this study was to determine the incidence of severe or greater acute radiation toxicity, and secondarily, response, survival, and local…”
Get more information

Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure by Ingle, J N, Pfeifle, D M, Green, S J, Kvols, L K, Brunk, S F, Reuter, N F, Krook, J E, Laurie, J A, Everson, L K, Marschke, R F

“…One hundred fifty-one women with advanced breast cancer who had failed prior chemotherapy were randomized to monthly courses of doxorubicin (60 mg/m2 I.V. day…”
Get more information